- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02196337
Salt Iodization: Meeting the Needs of Pregnancy, Lactation and Infancy (SIMPLIFY)
April 18, 2016 updated by: Maria Andersson, Swiss Federal Institute of Technology
Salt Iodization and the 1st 1000 Days: Does a USI Program Cover the Iodine Requirement of Pregnant and Lactating Women and Infants?
The purpose of this study is to determine whether universal salt iodization (USI) meets the iodine requirements of pregnant women, lactating women and infants.
Study Overview
Status
Completed
Conditions
Detailed Description
Because pregnant women, lactating women and infants are the groups most vulnerable to iodine deficiency and its irreversible consequences, programs should focus on these groups.
But like other mass fortification strategies, it is uncertain whether USI can meet the increased dietary requirements of pregnant women, lactating women and infants.
Objective of this study to test whether USI can meet the dietary requirements of iodine in women of reproductive age, pregnant women, lactating women and infants up to 2 years of age without causing excess iodine intake in school children and non-pregnant non-lactating women.
The study hypothesis is that USI, when fortified at adequate levels and applied to all salt consumed, including both household salt and salt used for processed foods, provides adequate dietary iodine for all population groups, except for weaning infants; while not posing any risk of excessive iodine intakes in other age groups.
Study Type
Observational
Enrollment (Actual)
8000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shanxi
-
Linfen, Shanxi, China, 041000
- Shanxi Institute for Prevention and Treatment of Endemic Disease
-
-
-
-
-
Zagreb, Croatia, 10000
- University of Zagreb
-
-
-
-
-
Manila, Philippines
- University of Santo Tomas Hospital
-
-
-
-
-
Zurich, Switzerland, 8092
- ETH Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 weeks to 44 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
In each of the four study countries, six population groups will be studied:
- women of reproductive age
- pregnant women
- lactating women
- young infants
- toddlers
- school-aged children
Description
Inclusion Criteria:
- living at study area for at least 6 months
- generally healthy
- no chronic medication
- no history of thyroid disease in the family
- no use of iodine containing dietary supplements during the last 6 months
- no use of iodine containing disinfectants for the last 6 months
- no use of X-ray / CT contrast agent or iodine containing medication within the last year
- in addition for women of reproductive age, pregnant women and breastfeeding women: age between 18 and 44 years old
- in addition for pregnant women: healthy pregnancy, singleton pregnancy (no twins or multiple pregnancy)
- in addition for breastfeeding women and breastfed infants: healthy pregnancy, singleton pregnancy (no twins or multiple pregnancy), baby born at full-term (in pregnancy week 38 to 42), the baby had normal birth weight (≥ 2500 g), baby not older than 6 months, baby currently completely breastfed (except for water, tea and juices)
- in addition for toddlers: between 6 and 24 months old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Women of reproductive age
Age: 18-44 years
|
Pregnant women
Age: 18-44 years
|
Lactating women
Age: 18-44 years
|
Young infants
Age: younger than 6 months
|
Toddlers
Age: between 6 and 24 months
|
School-aged children
Age: 6-12 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Urinary iodine concentration (µg/L)
Time Frame: 1 day
|
Participants will be assessed only once.
However, for 30% of the study participants urinary iodine concentration will be assessed in spot samples collected on two different days, spread over an expected average of 5 days.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thyroglobulin (µg/L)
Time Frame: 1 day
|
Thyroglobulin will be measured in all population groups
|
1 day
|
Breast milk iodine concentration (µg/L)
Time Frame: 1 day
|
Breast milk iodine concentration will be measured in lactating women.
|
1 day
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thyroid function (TSH, T4)
Time Frame: 1 day
|
Thyroid function (TSH, T4) will be measured where relevant.
|
1 day
|
Urinary sodium excretion (mg/day)
Time Frame: 1 day
|
Urinary sodium excretion will be assessed in school age children and women of reproductive age.
Participants will be assessed only once.
However, for urinary sodium excretion 30% of the study participants will be assessed in spot samples collected on two different days, spread over an expected average of 5 days
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Maria Andersson, PhD, ETH Zurich
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Dold S, Zimmermann MB, Jukic T, Kusic Z, Jia Q, Sang Z, Quirino A, San Luis TOL, Fingerhut R, Kupka R, Timmer A, Garrett GS, Andersson M. Universal Salt Iodization Provides Sufficient Dietary Iodine to Achieve Adequate Iodine Nutrition during the First 1000 Days: A Cross-Sectional Multicenter Study. J Nutr. 2018 Apr 1;148(4):587-598. doi: 10.1093/jn/nxy015.
- Dold S, Zimmermann MB, Aboussad A, Cherkaoui M, Jia Q, Jukic T, Kusic Z, Quirino A, Sang Z, San Luis TO, Vandea E, Andersson M. Breast Milk Iodine Concentration Is a More Accurate Biomarker of Iodine Status Than Urinary Iodine Concentration in Exclusively Breastfeeding Women. J Nutr. 2017 Apr;147(4):528-537. doi: 10.3945/jn.116.242560. Epub 2017 Feb 22.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
January 1, 2016
Study Completion (Actual)
January 1, 2016
Study Registration Dates
First Submitted
June 2, 2014
First Submitted That Met QC Criteria
July 18, 2014
First Posted (Estimate)
July 22, 2014
Study Record Updates
Last Update Posted (Estimate)
April 19, 2016
Last Update Submitted That Met QC Criteria
April 18, 2016
Last Verified
April 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EK 2013-N-82
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iodine Deficiency
-
DTU National Food InstituteUniversity Hospital Bispebjerg and FrederiksbergRecruitingDiet Habit | Iodine Deficiency | Iodine ToxicityDenmark
-
Universidade do PortoHospital de Braga; NOVA Medical School; Centro Hospitalar De São João, E.P.E.; Centro... and other collaboratorsCompletedIodine Deficiency | Iodine Status in PregnancyPortugal
-
Mahidol UniversityCompleted
-
University of GlasgowCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyUNICEF; Pan American Health OrganizationCompletedIodine DeficiencyAntigua and Barbuda, Barbados, Belize, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago
-
Swiss Federal Institute of TechnologyCompletedIodine DeficiencyMorocco
-
Mahidol UniversityETH Zurich; Iodine Global NetworkCompleted
-
University of BergenNational Dairy Council; Institute of Marine ResearchCompleted
-
University of BergenInstitute of Marine ResearchCompleted